Synthesis and evaluation of novel boron-containing complexes of potential use for the selective treatment of malignant melanoma

Journal of Medicinal Chemistry

Volumn 51, Issue 20, 2008, Pages 6604-6608

  Bonjoch, Josep ^a   Drew, Michael G B ^b   González, Asensio ^a   Greco, Francesca ^b   Jawaid, Samaila ^b   Osborn, Helen M I ^b   Williams, Nana Aba O ^b   Yaqoob, Parveen ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

9 METHOXY 9 BORABICYCLO[3.3.1]NONANE; AMINO ACID DERIVATIVE; BICYCLO COMPOUND; BORON DERIVATIVE; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL REACTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG ACCUMULATION; DRUG MECHANISM; DRUG OXIDATION; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME MECHANISM; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; NEUTRON CAPTURE THERAPY; OXIMETRY;

BORON COMPOUNDS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MELANOMA; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 54549105752     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm8007745     Document Type: Article

References (17)

1. Soloway, A. H.; Tjarks, W.; Barnum, B. A.; Rong, F. G.; Barth, R. F.; Codogni, I. M.; Wilson, J. G. The chemistry of neutron capture therapy. Chem. Rev. 1998, 98, 1515-1562.
2. (a) Mehta, S. C.; Lu, D. R. Targeted drug delivery for boron neutron capture therapy. Pharm. Res. 1996, 13, 344-351.
3. (b) Kabalka, G. W.; Yao, M.-L. Synthesis of 1-amino-3-[(dihydroxyboryl) methyl]-cyclobutanecarboxylic acid as a potential therapy agent. J. Org. Chem. 2004, 69, 8280-8286, and references therein.
4. Mishima, Y. Melanogenesis investigation leading to selective melanoma neutron capture theory and diagnosis. J. Dermatol. 1994, 21, 907-914.
5. Chen, W.; Mehta, S. C.; Lu, D. R. Selective boron drug delivery to brain tumors for boron neutron capture therapy. Adv. Drug Delivery Rev. 1997, 26, 231-247.
6. Frederick Hawthorne, M.; Lee, M. W. A critical assessment of boron target compounds for boron neutron capture therapy. J. Neuro-Oncol. 2003, 62, 33-45.
7. Kabalka, G. W.; Nichols, T. L.; Smith, G. T.; Miller, L. F.; Khan, M. K.; Busse, P. M. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J. Neuro-Oncol. 2003, 62, 187-195.
8. (a) Ito, S.; Kate, T.; Ishikawa, K.; Kasugat, T.; Jimbow, K. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes. Biochem. Pharmacol. 1987, 35, 2007-2011.
9. (b) Prota, G.; d'Ischia, M.; Mascagna, D. Melanogenesis as a targeting strategy against metastatic melanoma - a reassessment. Melanoma Res. 1994, 4, 351-357.
10. (a) Jordan, A. M.; Khan, T. H.; Osborn, H. M. I.; Photiou, A.; Riley, P. A. Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of a targeted treatment for malignant melanoma. Bioorg. Med. Chem. 1999, 7, 1775-1780.
11. (b) Jordan, A. M.; Khan, T. H.; Malkin, H.; Osborn, H. M. I.; Photiou, A.; Riley, P. A. Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma. Bioorg. Med. Chem. 2001, 101, 1549-1558.
12. (c) Jordan, A. M.; Khan, T. H.; Malkin, H.; Osborn, H. M. I. Synthesis and analysis of urea and carbamate prodrugs as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). Bioorg. Med. Chem. 2002, 10, 2625-2633.
13. (d) Knaggs, S.; Malkin, H.; Osborn, H. M. I.; Williams, N. A. O.; Yaqoob, P. New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). Org. Biomol. Chem. 2005, 3, 4002-4010.
14. Kiger, W. S., III.; Lu, X. Q.; Harling, O. K.; Riley, K. J.; Binns, P. J.; Kaplan, J.; Patel, H.; Zamenhof, R. G.; Shibata, Y.; Kaplan, I. D.; Busse, P. M.; Palmer, M. R. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam. Appl. Radiat. Isot. 2004, 61, 1075-1081.
15. (a) González, A.; Granell, J.; Piniella, J. F.; Alvarez-Larena, A. Boron complexes of L-cysteine. Tetrahedron 1998, 54, 13313-13322.
16. (b) Diaz, S.; Gonzalez, A.; González de Riancho, S.; Rodriguez, A. Boron complexes of S-trityl-L-cysteine and S-tritylglutathione. J. Organomet. Chem. 2000, 610, 25-30.
17. Alfke, H.; Stö ppler, H.; Nocken, F.; Heverhagen, J. T.; Kleb, B.; Czubayko, F.; Klose, K. J. In vitro MR imaging of regulated gene expression. Radiology 2003, 228, 488-492.